Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 6:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2353–2376 of 79,372 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: 2 Clear all

Conditions: Post-Operative Ileus (POI)
Interventions: At-home bowel stimulation; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Healthy
Interventions: Motor imagery training, NO motor imagery training; Other
Lead sponsor: Ahmed Mahmoud Kadry; Other
Eligibility: 18 Years to 35 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Mequon, Wisconsin

Conditions: Weight Loss, BMD
Interventions: Weight Loss, Weight Maintenance; Behavioral
Lead sponsor: Rutgers University; Other
Eligibility: 50 Years to 72 Years · Male only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Castration-Resistant Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7
Interventions: Abiraterone Acetate, Laboratory Biomarker Analysis, Prednisone, Veliparib; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Male only
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 14
States / cities: Duarte, California • Los Angeles, California • South Pasadena, California + 10 more

Conditions: Maternal Psychological Distress, Postpartum Depression, Prenatal Stress
Interventions: Mindfulness Based Cognitive Therapy; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Respiratory Complication
Interventions: Arterial Blood Gas and Transcutaneous CO2 Monitor; Diagnostic Test
Lead sponsor: Memorial Health University Medical Center; Other
Eligibility: Not listed
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Savannah, Georgia

Conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neurotoxicity Syndrome, Pain, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
Interventions: Cytology Specimen Collection Procedure, Pharmacological Study; Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Up to 15 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Brown Adipose Tissue
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 2
States / cities: Chapel Hill, North Carolina

Conditions: Nicotine Dependence
Interventions: Nicotine, Vaporizer Device, Salt-HIgh Nicotine Unflavored (Product B), Free-Low Nicotine Tobacco Flavored (Product C), Salt-High Nicotine Tobacco Flavored (Product D); Drug · Device
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 21 Years to 55 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Alcohol Use Disorder (AUD), PTSD
Interventions: CBT + expressive writing, Wait-List Control; Behavioral
Lead sponsor: University of Rhode Island; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Low Back Pain
Interventions: Hydrocodone ER, Placebo; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 61
States / cities: Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 54 more

Conditions: Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell
Interventions: AEG35156 antisense IV infusion; Drug
Lead sponsor: Aegera Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 4
States / cities: Burbank, California • Valhalla, New York • Cleveland, Ohio + 1 more

Conditions: Anthracycline-induced Cardiotoxicity, Lymphoma, Chemotherapy, Cardiotoxicity
Interventions: Sotagliflozin, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Peripheral Arterial Disease
Interventions: Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS); Device
Lead sponsor: Nipro Vascular Innovations Americas, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 20
States / cities: Scottsdale, Arizona • Merced, California • Fort Lauderdale, Florida + 16 more

Conditions: Pain, Postoperative
Interventions: Ibuprofen, Acetominophen; Drug
Lead sponsor: Boston University; Other
Eligibility: 4 Years to 6 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Brighton, Massachusetts

Conditions: Healthy Volunteers, Alcohol Use Disorder (AUD)
Interventions: Siemens 3T PRISMA MR Scanner, PET/CT Scanner, Suvorexant, Placebo; Device · Drug
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Speech
Interventions: TMS, somatosensory acuity measurement; Device · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Lumbar Fusion Surgery
Interventions: Intrathecal Morphine + Intrathecal Clonidine, Intrathecal Morphine; Drug
Lead sponsor: MaineHealth; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Hematologic Malignancies
Interventions: StemEx; Biological
Lead sponsor: Loyola University; Other
Eligibility: 55 Years to 73 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Cytomegalovirus Retinitis, HIV Infections
Interventions: Sargramostim, Ganciclovir; Drug
Lead sponsor: Schering-Plough; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 14
States / cities: Los Angeles, California • San Francisco, California • Sherman Oaks, California + 7 more

Conditions: Genitourinary Syndrome of Menopause (GSM)
Interventions: Vaginal estrogen tablet, Via Solv Wellness (Hyaluronic Acid Therapy); Drug · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 45 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Self-efficacy
Interventions: Motivational interviewing (MI); Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older · Female only
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Metastatic Pancreatic Adenocarcinoma
Interventions: Ipilimumab, Vaccine, FOLFIRINOX; Drug · Biological
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 3
States / cities: San Francisco, California • Baltimore, Maryland • St Louis, Missouri

Conditions: Postoperative Pain
Interventions: Q8003 (morphine sulfate and oxycodone hydrochloride), Placebo; Drug
Lead sponsor: QRxPharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 6
States / cities: Anaheim, California • Pasadena, Maryland • Altoona, Pennsylvania + 2 more

Search by objective public record fields.

At-Home Bowel Stimulation

The Effect of Motor Imagery Dosage on Motor Learning in Healthy Adults

The Effect of Weight Loss on Bone in Men

Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Mindfulness Based Cognitive Therapy (MBCT) During Pregnancy

Correlation of CO2 Measured by Blood Gas vs Transcutaneous Monitor

Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

Detection of Brown Adipose Tissue by Magnetic Resonance Imaging

Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building

Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets

A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)

ITM vs ITM+Clonidine for Lumbar Fusions

Umbilical Cord Transplantation for the Elderly Population

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

Motivational Interviewing Intervention for Intimate Partner Violence

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain